Sectors · Pharma
Pharma & life sciences
Valuable intellectual property, strict data integrity expectations and complex supply chains put pharma companies under sustained, sophisticated attack.
01
The pressure
IP worth stealing, data that must hold.
Research IP makes pharma a target for sophisticated actors, while data-integrity expectations and extended supply chains widen the attack surface considerably.
02
Frameworks that apply
The standards in play.
- ISO 27001
- UK GDPR and data-integrity good practice
03
How we help
Protection and proof, joined up.
- Protecting research IP with layered identity and endpoint controls
- Supply-chain and third-party risk management
- ISO 27001, kept audit-ready
- 24×7 detection across a complex estate
Protecting valuable research?
Let’s talk about securing your IP, your data integrity and your supply chain.
Book a call